Christopher Peetz
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $16.3M
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Sep 3SEC | MIRMMirum Pharmaceuticals, Inc. | Sell Plan | 8,312216,128 held (−4%) | $98.08 | $815K | -12.3% |
| Sep 3SEC | MIRMMirum Pharmaceuticals, Inc. | Sell Plan | 21,688194,440 held (−10%) | $98.91 | $2.1M | -13.0% |
| Aug 11SEC | MIRMMirum Pharmaceuticals, Inc. | Sell Plan | 11,683202,626 held (−5%) | $98.51 | $1.2M | -12.7% |
| Aug 11SEC | MIRMMirum Pharmaceuticals, Inc. | Sell Plan | 6,017196,609 held (−3%) | $99.25 | $597K | -13.3% |
| Aug 11SEC | MIRMMirum Pharmaceuticals, Inc. | Sell Plan | 2,300194,309 held (−1%) | $100.14 | $230K | -14.1% |
| Jul 8SEC | MIRMMirum Pharmaceuticals, Inc. | Sell Plan | 12,134202,175 held (−6%) | $121.65 | $1.5M | -29.3% |
| Jul 8SEC | MIRMMirum Pharmaceuticals, Inc. | Sell Plan | 4,181197,994 held (−2%) | $122.34 | $512K | -29.7% |
| Jul 8SEC | MIRMMirum Pharmaceuticals, Inc. | Sell Plan | 1,975196,019 held (−1%) | $123.74 | $244K | -30.5% |
| Jul 8SEC | MIRMMirum Pharmaceuticals, Inc. | Sell Plan | 1,710194,309 held (−1%) | $124.79 | $213K | -31.1% |
| Jun 2SEC | MIRMMirum Pharmaceuticals, Inc. | Sell Plan | 2,602221,707 held (−1%) | $94.64 | $246K | -9.1% |
| Jun 2SEC | MIRMMirum Pharmaceuticals, Inc. | Sell Plan | 16,595205,112 held (−7%) | $95.34 | $1.6M | -9.8% |
| Jun 2SEC | MIRMMirum Pharmaceuticals, Inc. | Sell Plan | 6,926198,186 held (−3%) | $96.15 | $666K | -10.5% |
| Jun 2SEC | MIRMMirum Pharmaceuticals, Inc. | Sell Plan | 1,973196,213 held (−1%) | $97.56 | $192K | -11.8% |
| Jun 2SEC | MIRMMirum Pharmaceuticals, Inc. | Sell Plan | 1,021195,192 held (−1%) | $98.20 | $100K | -12.4% |
| Jun 2SEC | MIRMMirum Pharmaceuticals, Inc. | Sell Plan | 883194,309 held (−0%) | $99.66 | $88K | -13.7% |
| Mar 17SEC | MIRMMirum Pharmaceuticals, Inc. | Sell | 40,985194,309 held (−17%) | $91.98 | $3.8M | -6.5% |
| Feb 3SEC | MIRMMirum Pharmaceuticals, Inc. | Sell | 9,108160,294 held (−5%) | $103.30 | $941K | -16.7% |
| Jan 27SEC | MIRMMirum Pharmaceuticals, Inc. | Sell | 6,831169,402 held (−4%) | $96.19 | $657K | -10.6% |
| Jan 23SEC | MIRMMirum Pharmaceuticals, Inc. | Sell | 7,098163,733 held (−4%) | $93.33 | $662K | -7.8% |
- Sell
CEO Christopher Peetz sold $815K of MIRM at $98.08 — pre-scheduled 10b5-1 plan sale.
- Sell
CEO Christopher Peetz sold $2.1M of MIRM at $98.91 — pre-scheduled 10b5-1 plan sale.
- Sell
CEO Christopher Peetz sold $1.2M of MIRM at $98.51 — pre-scheduled 10b5-1 plan sale.
- Sell
CEO Christopher Peetz sold $597K of MIRM at $99.25 — pre-scheduled 10b5-1 plan sale.
- Sell
CEO Christopher Peetz sold $230K of MIRM at $100.14 — pre-scheduled 10b5-1 plan sale.
- Sell
CEO Christopher Peetz sold $1.5M of MIRM at $121.65 — pre-scheduled 10b5-1 plan sale.